Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma … [+]
Takeda’s (NYSE: TAK) (TSE:4502)…
Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma … [+]
Takeda’s (NYSE: TAK) (TSE:4502)…